Circulating CXCL9 is a predictor of poor prognosis in HNSCC;51 however, in the context of CXCR3 expression in bintrafusp alfa responder tumors, it has the potential to induce antitumor immunity rather than promote tumor expansion. This evidence concerns the gene CXCR3 and head and neck squamous cell carcinoma.